Hosny E A
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Pharm Acta Helv. 1998 Jan;72(5):255-61. doi: 10.1016/s0031-6865(97)00040-x.
The production of spheres loaded with diclofenac sodium by the cross linking technique was achieved. The hydrophilic polymer sodium carboxymethylcellulose (Na-CMC) which gels in the presence of a cross linking agent, aluminum chloride (AlCl3), was used as a matrix forming agent for the bead production. To obtain a regular and uniform rate of drug release, the produced beads were coated with sodium alginate to increase the pathway of the diffused medium. Two processing variables were studied, the flocculating agent concentration (20, 40 and 60% w/v) and different coating times (15, 30 and 60 min). The results show that the higher concentrations of aluminum chloride (40 and 60% w/v) produced more uniform and rounded beads than that prepared using 20% w/v salt. The particle size of the core beads decreased insignificantly (P > 0.05) as the flocculating agent concentration increased. The coating time did not affect the particle size of the coated beads within the same concentration of aluminum chloride. The dissolution studies showed that the release rate of diclofenac sodium from the core beads increased with the increase of AlCl3 concentration and that the rate of drug release was markedly reduced after the coating of the core beads with Na-alginate. The results also show a linear relationship for drug release over a 4-5 h period from the core beads where it showed a longer straight line relationship (7 h) for the coated beads. The coating of the Al-CMC beads, prepared using 60% w/v AlCl3.6H2O, with 2% w/v aqueous solution of Na-alginate resulted in a significant (P < 0.05) sustaining action of the Al-CMC beads as indicated by the shift in Tmax from 1.7 +/- 0.84 to 3 +/- 0.71 h and the prolongation of the MRT from 7.86 +/- 0.54 to 10.82 +/- 1.33 h. The Cmax increased significantly from 5.43 +/- 2.91 to 11.66 +/- 6.18 micrograms/ml while the AUC0-->24 increased insignificantly (P > 0.05) from 39.82 +/- 26.61 to 57.92 +/- 25.58 micrograms h/ml resulting in a relative bioavailability of 145.45% relative to Al-CMC beads.
通过交联技术成功制备了负载双氯芬酸钠的微球。亲水性聚合物羧甲基纤维素钠(Na-CMC)在交联剂氯化铝(AlCl3)存在下会形成凝胶,被用作制备微球的基质形成剂。为了获得规则且均匀的药物释放速率,将制备的微球用海藻酸钠包衣以增加扩散介质的路径。研究了两个工艺变量,即絮凝剂浓度(20%、40%和60% w/v)以及不同的包衣时间(15分钟、30分钟和60分钟)。结果表明,与使用20% w/v盐制备的微球相比,较高浓度的氯化铝(40%和60% w/v)制备出的微球更均匀、更圆润。随着絮凝剂浓度增加,核心微球的粒径减小不显著(P > 0.05)。在相同浓度的氯化铝条件下,包衣时间对包衣微球的粒径没有影响。溶出度研究表明,双氯芬酸钠从核心微球的释放速率随AlCl3浓度的增加而增加,并且在用海藻酸钠包衣核心微球后,药物释放速率显著降低。结果还表明,核心微球在4 - 5小时内药物释放呈线性关系,而包衣微球则呈现更长的直线关系(7小时)。用2% w/v的海藻酸钠水溶液对使用60% w/v AlCl3·6H2O制备的Al-CMC微球进行包衣,导致Al-CMC微球具有显著(P < 0.05)的缓释作用,表现为Tmax从1.7 ± 0.84小时变为3 ± 0.71小时,MRT从7.86 ± 0.54小时延长至10.82 ± 1.33小时。Cmax从5.43 ± 2.91显著增加至11.66 ± 6.18微克/毫升,而AUC0→24从39.82 ± 26.61微克·小时/毫升无显著增加(P > 0.05)至57.92 ± 25.58微克·小时/毫升,相对于Al-CMC微球,相对生物利用度为145.45%。